Marie Charissoux
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 13, 2025
Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: Long-term results from a prospective registry study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 29, 2025
Image-guided intensity-modulated radiotherapy with reduced margins in patients with prostate cancer: Results of the RCMIGI randomized phase II trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 15, 2025
Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
Journal: Journal of neurosurgery
Published: August 22, 2023
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
Journal: Neuro-oncology
Published: July 07, 2023
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.
Journal: Radiation oncology (London, England)
Published: February 13, 2023
Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results.
Journal: Journal of clinical medicine
Published: December 17, 2022
Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 18, 2022
Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?
Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 12, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer.
Journal: Frontiers in oncology
Published: May 06, 2022
Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study.
Journal: Cancers
Published: February 25, 2022
Last Updated: 09/26/2026